Home  >  Products  >  MAP3K7IP2 (mitogen-activated protein kinase kinase kinase 7 interacting protein 2) Blocking Peptide (100ug)
MAP3K7IP2 (mitogen-activated protein kinase kinase kinase 7 interacting protein 2) Blocking Peptide (100ug)

MAP3K7IP2 (mitogen-activated protein kinase kinase kinase 7 interacting protein 2) Blocking Peptide (100ug)


Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-MAP3K7IP2 antibody (Catalogue #: ARP32402_P050) made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Presku: AAP32402
Size: 100 ug
Weight: 76kDa
Gene: 23118
Format: Lyophilized powder
Target: MAP3K7IP2 is an activator of MAP3K7/TAK1, which is required for for the IL-1 induced activation of NF.:B and MAPK8/JNK. This protein forms a kinase complex with TRAF6, MAP3K7 and TAB1, thus serving as an adaptor linking MAP3K7 and TRAF6. This protein, TAB1, and MAP3K7 also participate in the signal transduction induced by TNFSF11/RANKl through the activation of the receptor activator of NF.:B (TNFRSF11A/RANK), which may regulate the development and function of osteoclasts.